Open-label study of intramuscular inactivated influenza A/H5N1 vaccine in healthy children aged 2 years to 10 years.
Phase of Trial: Phase I/II
Latest Information Update: 10 Jun 2011
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions
- 13 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 26 Apr 2007 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
- 27 Feb 2007 New trial record.